在iTIND手术前使用Schelin导管进行经尿道前列腺内麻醉（TUIA）。
Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure.
作者信息
Secco Silvia, Olivero Alberto, Longoni Mattia, Dell'Oglio Paolo, Tappero Stefano, Dibilio Edoardo, Saccucci Tommaso, Siena Giampaolo, Bocciardi Aldo Massimo, Galfano Antonio, Cindolo Luca
机构信息
Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS Ospedale San Raffaele, Milan, Italy.
出版信息
Prostate Cancer Prostatic Dis. 2024 Sep 10. doi: 10.1038/s41391-024-00892-2.
BACKGROUND/OBJECTIVES: Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning.
SUBJECTS/METHODS: Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS).
RESULTS
No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA.
CONCLUSIONS
SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.
背景/目的：为支持良性前列腺增生（BPH）手术的微创原则，我们在iTIND定位前首次使用Schelin导管®（SC）对经尿道前列腺内麻醉（TUIA）进行了评估。
受试者/方法：在纳入的23例患者中，11例（48%）通过SC接受TUIA，其余患者接受标准麻醉方案。使用视觉模拟量表（VAS）评估疼痛。
结果
在装置植入和取出过程中，两组之间未观察到疼痛差异。相反，在24小时（1.0对3.0）和48小时（1.0对2.5）随访时，TUIA组报告的VAS中位数得分显著更低。
结论
SC TUIA在iTIND手术过程中提供了有效的疼痛控制，支持其在门诊环境中的应用。
Zotero 插件